NeRRe Therapeutics

NeRRe Therapeutics

Verified
Develops clinical and pre-clinical neurokinin receptor antagonists

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
EBITDA(2m)(9m)(9m)(10m)(6m)--
  • Edit

Recent News about NeRRe Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.